Title of article :
Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice
Author/Authors :
Ansari ، نويسنده , , Mohammed Javeed I. and Fiorina، نويسنده , , Paolo and Dada، نويسنده , , Shirine and Guleria، نويسنده , , Indira and Ueno، نويسنده , , Takuya and Yuan، نويسنده , , Xueli and Trikudanathan، نويسنده , , Subbulaxmi and Smith، نويسنده , , R. Neal and Freeman، نويسنده , , Gordon and Sayegh، نويسنده , , Mohamed H.، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2008
Pages :
8
From page :
140
To page :
147
Abstract :
Islet allografts are subject to alloimmune and autoimmune destruction when transplanted into autoimmune prone animals or humans. The ICOS-B7h pathway plays a role in alloimmune responses, but its function in autoimmunity against islet cells is controversial. We investigated the role of ICOS signaling in autoimmune and alloimmune responses in NOD mice. ICOS blockade prevents development of spontaneous disease in pre-diabetic NOD mice. Furthermore, while ICOS blockade prolongs graft survival in a fully mismatched non-autoimmune islet allograft model in C57BL/6 recipients, it has no beneficial effect in reversing diabetes in models of islet transplantation in NOD mice involving autoimmunity alone or both allo- and autoimmunity. Interestingly, ICOS blockade is effective in prolonging heart allograft (not subject to tissue-specific autoimmunity) survival in NOD mice. We conclude that in islet transplantation and autoimmune diabetes, ICOS blockade can be effective in inhibiting alloimmunity and preventing autoimmunity but is ineffective in inhibiting recurrence of autoimmunity.
Keywords :
Costimulation , SIROLIMUS , Autoimmune diabetes , islet transplantation , ICOS , NOD mice
Journal title :
Clinical Immunology
Serial Year :
2008
Journal title :
Clinical Immunology
Record number :
1852820
Link To Document :
بازگشت